LYN and cancer: PTPROt has dual impact on B cells via dephosphorylating a key member of the BCR signaling pathway, Lyn at its active and inhibitory tyrosine residues under different circumstances, albeit it is mainly responsible for the deceleration of B cell-related cancer progression.